Yazar "Filippova, E." seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients [Meeting Abstract](Elsevier Science Inc, 2021) Peled, N.; Gillis, R.; Kilickap, S.; Froesch, P.; Orlov, S.; Filippova, E.; Demirci, U.[Abstract Not Available]Öğe Telisotuzumab Vedotin (teliso-v) Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer(Elsevier Science Inc, 2021) Camidge, D. R.; Moiseenko, F.; Cicin, I.; Horinouchi, H.; Filippova, E.; Bar, J.; Lu, S.[Abstract Not Available]Öğe Telisotuzumab vedotin monotherapy in patients with previously treated c-Met plus advanced non-small cell lung cancer(Elsevier, 2022) Horinouchi, Hidehito; Goldman, J. W.; Moiseenko, F.; Cicin, I.; Filippova, E.; Bar, J.; Tomasini, P.[Abstract Not Available]Öğe Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met plus Advanced Non-Small Cell Lung Cancer: Stage 2(Elsevier Science Inc, 2021) Goldman, J.; Moiseenko, F.; Cicin, I.; Horinouchi, H.; Filippova, E.; Bar, J.; Lu, S.[Abstract Not Available]
